StonvexLoading…
StonvexStonvexStonvexCore line items from WEX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-21 | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $746.24M | $462.20M | $1.85B | $1.38B | $898.70M |
Operating Income | Not available | $158.20M | $663.90M | $497.60M | $314.00M |
Net Income | Not available | $77.70M | $304.10M | $219.80M | $68.10M |
EPS (Diluted) | $5.10 | $2.22 | $8.47 | $6.07 | $3.78 |
Total Assets | Not available | $15.43B | $14.40B | $14.43B | $14.67B |
Total Liabilities | Not available | $14.15B | $13.16B | $13.31B | $13.69B |
Cash & Equivalents | Not available | $633.50M | $905.80M | $812.90M | $772.60M |
Free Cash Flow OCF − CapEx | Not available | $-368.30M | $313.70M | $57.40M | $-284.20M |
Shares Outstanding | Not available | 34.70M | 34.30M | 34.30M | 34.30M |